The adaptive immune system in vertebrates relies on an enormous repertoire of antigen receptors. The variable domains of antigen receptors are encoded by extensive arrays of variety, diversity and joining (V, D, and J) gene segments flanked by conserved recombination signal sequences (RSSs) [1] . During the early lymphoid-specific process known as V(D)J recombination, RAG1 and RAG2 recognize and pair two RSSs based on the 12/23 rule and introduce a pair of double-strand breaks (DSB) between each RSS and its adjoining coding segment [2] . The non-homologous DNA end-joining pathway then rejoins the coding segments together and generates functional receptors [3] .
The adaptive immune system in vertebrates relies on an enormous repertoire of antigen receptors. The variable domains of antigen receptors are encoded by extensive arrays of variety, diversity and joining (V, D, and J) gene segments flanked by conserved recombination signal sequences (RSSs) [1] . During the early lymphoid-specific process known as V(D)J recombination, RAG1 and RAG2 recognize and pair two RSSs based on the 12/23 rule and introduce a pair of double-strand breaks (DSB) between each RSS and its adjoining coding segment [2] . The non-homologous DNA end-joining pathway then rejoins the coding segments together and generates functional receptors [3] .
Murine RAG1 contains 1 040 amino acids, and RAG2 contains 527 amino acids. Biochemical studies have confirmed that the core regions of RAG1 (aa 384-1 008) and RAG2 (aa 1-387) are fundamental for the cleavage reaction in vitro [4] . Core RAG1 is capable of recognizing RSSs and can form tetramers with RAG2 in which the DDE triad is responsible for the DNA cleavage activity [5] . Core RAG2 contains Kelch motifs that assist RAG1 binding and cutting of the RSSs [6] . The plant homology domain within the RAG2 non-core region has recently been shown to bind histone H3K4Me3 and activate the recombination reaction [7, 8] . Regarding the non-core region, especially the N-terminal region of RAG1 (aa 1-383), several conserved clusters of basic residues have been identified within residues 1-264 [9] . This region is thought to bind to a zinc ion and associate with KPNA1 and SRP1 [10] [11] [12] . A recently defined WW-like domain (aa 179-205) might mediate protein-protein interactions [13] . Residues 265-383 of RAG1 contain a C3HC4 ring-finger domain harboring E3 ubiquitin ligase activity [14] . However, the roles of these domains or motifs in V(D)J recombination have not been fully elucidated.
The impaired V(D)J recombination in core RAG1 knock-in mice suggests that non-core RAG1 increases the efficiency and accuracy of recombination, yet quite a number of lymphocytes can mature, indicating that non-core RAG1 is dispensable for basic recombination activity [15] . Nevertheless, in some Omenn syndrome (OS) patients who carry mutations within the non-core region of RAG1 (including a conserved cysteine residue mutation in the ring-finger domain, RAG1 C328Y ), T and B lymphocyte are barely detected. The severe defects of lymphocyte development caused by mutations within non-core RAG1 raise the key question of how non-core RAG1 modulates the V(D)J recombination.
Previous studies of the RAG1 ring-finger domain have revealed that the loss of E3 ubiquitin ligase activity correlates with decreased V(D)J recombination of episomal substrates [16, 17] . Histone H3 was recently defined as a ubiquitylation substrate of the RAG1 ring-finger domain, suggesting a chromatin-mediated regulation of V(D)J recombination [18, 19] . Whether and how RAG1's E3 ubiquitin ligase activity participates in V(D)J recombination in vivo is unknown.
In this study, we constructed a murine model (RAG1 KI/KI mice) carrying the RAG1 C325Y mutation that corresponds to the RAG1 C328Y mutation in OS patients. We found that V(D)J recombination was severely impaired at the cleavage stage, and this was accompanied by decreased mono-ubiquitylation of histone H3 in RAG1 KI/KI mice. When we compared the cleavage abilities of RAG1 C325Y and wild-type RAG1 using different substrates, we found that RAG1 C325Y was specifically unable to catalyze the recombination of chromatinized substrates. Further analyses suggest that histone H3 recruits RAG1 by interacting with the N-terminal 218 amino acids of RAG1 but subsequently restrains its cleavage activity toward RSSs. Our data provide evidence for a model in which ubiquitylation of histone H3 mediated by the ring-finger domain triggers the release of RAG1, allowing its transition into the cleavage phase. Altogether, ubiquitylation of histone H3 mediated by the RAG1 ring-finger domain is required for RAG1 to catalyze chromosomal V(D)J recombination.
Results

T and B lymphocyte development is severely blocked in RAG1
KI/KI mice To investigate the role of the N terminal region of RAG1 in V(D)J recombination, we constructed a murine model carrying the RAG1 C325Y mutation (Supplementary information, Figure S1A -S1C). In agreement with the immune deficiency of OS patients, a severe defect in early T lymphocyte development was observed in the RA-G1 KI/KI mice. Thymic cellularity was drastically reduced with an obvious arrest of thymocyte differentiation at the CD4 − CD8 − double-negative (DN) stage ( Figure 1A and 1B). The expression profile of CD44 and CD25 revealed that the DN thymocytes accumulated at the DN3 stage with a relative depletion of the DN4 subset ( Figure 1C and 1D). The numbers of CD4, CD8 and γδ T cells were severely reduced in the spleen (Figure 1E and 1F; Supplementary information, Figure S1D ). A deficiency in early B cell differentiation was also detected in the bone marrow ( Figure 1G and 1H) . The majority of early B cells stopped at the Pro-B stage ( Figure 1I and 1J ). Mature B lymphocytes were barely detected in the spleen ( Figure 1K and 1L) , whereas macrophage and NK cell development in the mutant mice was comparable to that of their wild-type littermates (Supplementary information, Figure S1D ). Altogether, we found that the RAG1 KI/KI mice exhibited severe defects in early T and B lymphocyte differentiation.
Deficiency in RAG1 KI/KI mice is due to diminished V(D)J rearrangement
Given that the development of thymocytes stopped at the DN3 stage and the B-cell development stopped at the Pro-B stage, we inferred that RAG1 C325Y failed to catalyze V(D)J recombination in vivo. Thus we assessed the expression of the TCRβ chain and found that the proportions of DN3 and DN4 thymocytes expressing TCRβ dropped dramatically in the RAG1 KI/KI mice ( Figure 2A ). Next, we examined the recombination products from RAG1 KI/KI mice. After genomic DNA was prepared from DN3 thymocytes and Pro-B cells, we performed PCR analysis to measure the joints of the Tcrb and Igh rearrangement. As expected, the recombination products of D β -J β were markedly lower in the RAG1 KI/KI mice than in their wild-type littermates ( Figure 2B ). The complete V β -DJ β assembly was barely detected in the mutant mice ( Figure 2B ). The levels of D H -J H and V H -DJ H rearrangement also decreased in Pro-B cells ( Figure  2C ). The levels of endogenous D β 1-J β 1.6 coding joint and D β 1-J β 1.1 signal joint in RAG1 KI/KI mice were reduced to one-tenth of that detected in wild-type mice as shown by real-time PCR analysis ( Figure 2D ).
To exclude the possibility that the impaired lymphocyte development was independent of V(D)J recombination, the OT-1 TCR transgene was introduced into the knock-in mice. Thymocyte differentiation was rescued by the ectopic TCR expression ( Figure 2E and 2F). Taken together, our data showed that the murine RAG1 C325Y failed to mediate V(D)J recombination in vivo, leading to abrogated lymphocyte development.
RAG1
C325Y largely retains DNA endonuclease activity toward episomal substrates
The V(D)J recombination process is generally divided into a cleavage phase and a joining phase [20] . Thus we used LM-PCR to assess the RSS breaks in DN3 thy- − cells were gated and analyzed for CD44 and CD25 expression. The cell number of the DN subsets is shown (mean ± SEM; n = 3; **P < 0.01 and *P < 0.05 by Student's t-test; N.S., no significance). (E, F) Mature T lymphocytes are reduced in the periphery. Splenocytes were stained with anti-CD4 and anti-CD8 antibodies. The number of CD4 and CD8 lymphocytes in spleen is shown (mean ± SEM; n = 3; **P < 0.01 and *P < 0.05 by Student's t-test). (G, H) Early B cell development is impaired. Cells isolated from femurs were stained with anti-B220 and anti-IgM antibodies. The number of indicated B cell subsets in the bone marrow is shown (mean ± SEM; n = 4; ***P < 0.001 and *P < 0.05 by Student's t-test). (I, J) B220 + IgM − cells were gated and analyzed for CD43 expression. The number of pro-B-cell and pre-B-cell subsets are shown (mean ± SEM; n = 4; **P < 0.01 and *P < 0.05 by Student's t-test). (K, L) Mature B cells were barely detected in the spleen. Splenocytes were stained with anti-B220 and anti-IgM antibodies. The number of indicated B-cell subsets in spleen is shown (mean ± SEM; n = 4; ***P < 0.001 by Student's t-test; N.S., no significance). All mice were analyzed at 4-5 wk of age.
mocytes. Contrary to the previous expectation [18] , we were unable to detect any accumulation of signal ends in RAG1 KI/KI mice ( Figure 3A ). Collectively, the diminished level of signal ends accompanied by the considerable amount of remaining D β -J β germline bands ( Figure 2B ) suggests that V(D)J recombination stops at the cleavage phase in RAG1 KI/KI mice. Given the cleavage deficiency observed in RAG1 KI/KI mice, we wondered whether the ring-finger domain mutation influenced the expression level of RAG1. Therefore, we fused GFP to the C-termini of RAG1 and RAG1
C325Y
and introduced these constructs into thymocytes and HEK-293T cells by transient transfection. FACS analysis showed that the two constructs showed similar expression levels and fluorescence intensity in thymocytes and in HEK-293T cells ( Figure 3B ). Additionally, similar level of protein expression in vivo was detected by western blots of WT and RAG1 KI/KI DN3 thymocytes ( Figure 3C ). We then questioned whether the ring-finger mutation interfered with RAG1's nuclease activity. Intriguingly, in the recombination experiments we performed with HEK-293T cells, RAG1 and RAG1 C325Y generated comparable 
-test). (F)
The recombination products of pJH289 and pJH290 in HEK-293T were analyzed by PCR. Un, unrearranged; CJ, coding joint; SJ, signal joint. PCR amplification was performed on serial three-fold dilutions of template DNA. Control PCR amplification of a non-rearranging locus on pJH289 and pJH290 was performed to normalize the input DNA. All results are representative of three independent experiments. levels of DNA DSB in the episomal substrates ( Figure  3D ). The formation of recombination products catalyzed by RAG1
C325Y was reduced to 50% of that catalyzed by RAG1 ( Figure 3E and 3F ). Thus the difference in the recombination activity between RAG1 and RAG1 C325Y was smaller toward episomal substrates. As reported previously, the transiently tansfected episomal substrates consist of un-chromatinized and chromatinized DNA [21, 22] . Taken together, these results suggest that the chromatin might be a decisive factor obstructing RAG1 C325Y recombination activity in vivo.
We also analyzed the sequences of D β -J β recombination products and found that the signal joints from the mutant mice were similar to those from wild-type mice; however, certain differences between the coding joints were detected (Supplementary information, Figure S2A -S2C). These results were reminiscent of that of the core RAG1 knock-in study [23] .
V(D)J recombination impairment in RAG1 KI/KI mice correlates with decreased mono-ubiquitylation of histone H3
The C325Y mutation in the RAG1 ring-finger domain is known to abolish its E3 ubiquitin ligase activity toward histone H3 [18, 19] . These observations and our results, strongly suggest that the ring finger's E3 activity regulates V(D)J recombination through a chromatin-mediated mechanism. Thus, we hypothesized that failure to ubiquitylate histone H3 may underlie the severe V(D)J recombination impairment observed in RAG1 KI/KI mice. As shown in Figure 4A , histone H3 was less mono-ubiquitylated in RAG1 KI/KI DN3 thymocytes compared to wild type DN3 thymocytes. A lower level of mono-ubiquitylated histone H3 was detected in the RAG1 KI/KI thymocytes than in the RAG2 knock-out thymocytes ( Figure 4B ), suggesting that the histone H3 mono-ubiquitylation is cleavage-independent. We then performed a deletion analysis of histone H3 and found that the N-ter- minal region of RAG1 preferentially mono-ubiquitylated histone H3 within the region between residues 41 and 135 ( Figure 4C ). This region of histone H3 contains two conserved lysine residues (K79, K122) that have been reported to be ubiquitylated by RAG1 in vitro [19] . Further substitution of lysine with arginine indicated that lysine 79 is most likely the ubiquitylation target ( Figure 4D) .
We next performed bone marrow transfer experiments to overexpress mutant histone H3 in which lysine 79 had been replaced with arginine in otherwise wild-type bone marrow cells. We found that overexpression of H3 K79R led to a partial arrest of lymphocyte development (Figure 4E-4G ; Supplementary information, Figure S3 ). To exclude the possibility that the impaired lymphocyte development was independent of V(D)J recombination, we also performed bone marrow transfer experiments to overexpress mutant histone H3 in OT-1 TCR transgenic bone marrow cells. Overexpression of the H3 mutant no longer hindered OT-1 thymocyte differentiation ( Figure  4H ). Taken together, our results suggest that the decreased mono-ubiquitylation of histone H3 is an important reason for the observed V(D)J recombination impairment in RAG1 KI/KI mice. 
Mono-ubiquitylation of histone H3 releases RAG1 into the cleavage phase
To demonstrate the link between RAG1-mediated ubiquitylation of histone H3 and chromosomal RSS cleavage, we first analyzed the association between RAG1 and histone H3. Histone H3 is reported to specifically interact with the N terminal region of RAG1 [18] . By co-immunoprecipitation, we found the N-terminal 218 amino acids of RAG1 mediated interactions with histone H3 ( Figure 5A ). We further compared the association with the N-terminal region of RAG1 between histone H3 and mono-ubiquitylated histone H3. Intriguingly, the N-terminal region of RAG1 preferentially interacted with un-ubiquitylated histone H3 in HEK-293T cells ( Figure  5B ). Based on these results, we speculate that histone H3 may spatially immobilize RAG1 by associating with the N-terminal 218 amino acids of RAG1 (RAG1 ), and ubiquitylation of histone H3 mediated by the ring-finger domain triggers the release of RAG1 from the nucleosomes. It is possible that the failure to ubiquitylate his- KI/KI mice could be rescued once RAG1 is dissociated from histone H3. By co-immunoprecipitation, we found that overexpression of RAG1 abrogated the association between the N-terminal region of RAG1 and histone H3 ( Figure 5C ). We then used bone marrow transfer to overexpress the N-terminal 218 amino acids of RAG1 in bone marrow cells from RAG1 KI/KI mice. A moderate restoration of thymocyte differentiation was observed with increased Tcrb rearrangement (Figure 5D-5F ; Supplementary information, Figure S4 ), supporting that releasing RAG1 from histone H3 initiates chromosomal V(D)J recombination.
Discussion
In this study, we report that V(D)J recombination is abrogated at the initiation step, correlating with decreased histone H3 mono-ubiquitylation in RAG1 C325Y knock-in mice. Our results provide a ring-finger domain-dependent model in which histone H3 recruits and restrains RAG1 at the recombination center by associating with the N-terminal 218 amino acids of RAG1. Ubiquitylation of histone H3 mediated by the RAG1 ring-finger domain then triggers the transition of RAG1 into the cleavage phase ( Figure 6 ).
We observed a decrease in bulk histone H3 ubiquitylation in RAG1 C325Y DN3 thymocytes compared to wild type DN3 thymocytes ( Figure 4A and 4B) . Previous study has reported that accompanied by RAG2, RAG1 protein binding occurs in a highly focal manner to a small region of active chromatin encompassing antigen receptor gene segments [24] . It is reasonable to speculate that the RAG1-H3 interaction and H3 ubiquitylation occur within the "recombination center" during V(D) J recombination. However, we could not rule out the possibility that RAG1 might mediate histone H3 ubiquitylation outside the recombination center, which needs further investigation in the future. During the early stage of T and B lymphocyte development, the chromosomal loci of antigen receptor genes undergo reversible chromatin changes, including histone modifications and DNA hypomethylation, etc. [25, 26] . Series of remodeling changes not only ensure the loci are open and accessible but also are involved in recruiting RAG2 via (H3K4Me3) and activating V(D)J recombination [27, 28] . An additional aspect suggested by our results is that un-ubiquitylated histone H3 at the recombination center recruits RAG1 by associating with the N-terminal 218 amino acids of RAG1 ( Figure 6A) , thus explaining the attenuated recombination efficiency in the core RAG1 knockin mice [15] and the recombination deficiency caused by NΔ13-135 RAG1 [29] . Our study provides an explanation for how full-length RAG1 locates to the recombination center. A recent study identified acetylated and phosphorylated histone H3.3 in Pro-B cells as a substrate for the E3 ubiquitin ligase activity of RAG1 [19] . The detailed mechanisms by which histones recruit RAG1 deserve further exploration.
The exact role of the non-core region of RAG1 during V(D)J recombination has been an open question for decades [20] . Biochemical studies have revealed a subsidiary role of the non-core, as core RAG1 is able to catalyze recombination in vitro [4] . The observation that V(D) J recombination in core RAG1 knock-in mice exhibits a lower efficiency and accuracy suggests that the non-core region of RAG1 acts as a positive regulator [23, 29] . Nevertheless, studies of core-RAG1 knock-in mice cannot determine the exact mechanism of non-core RAG1. Based on the results from our RAG1 KI/KI mice, the function of N-terminal RAG1 should be considered from two aspects. The correlation between the severe impairment of V(D)J recombination and the decreased ubiquitylation of histone H3 in vivo suggests that un-ubiquitylated histone H3 inhibits recombination by associating with the N-terminal 218 amino acids of RAG1. After RAG1 is loaded at the recombination center, multiple encounters with RSSs require the confinement of RAG1 to prevent any nonspecific cleavage until a stable paired (synaptic) complex assembles [20, 30] . It is plausible to speculate that the constitutive interaction between histone H3 and RAG1 prevents RAG1 from cleaving the RSSs ( Figure  6B ). The ring-finger domain's E3 activity towards histone H3 serves to release RAG1 to initiate the cleavage step ( Figure 6C ). Therefore, when we blocked the interaction between RAG1 and histone H3 in RAG1 C325Y knock-in mice, we observed elevated V(D)J recombination in thymocytes. This partial rescue suggests that the deficiency of RAG1 C325Y in vivo can be attributed to the constitutive interaction with un-ubiquitylated histones.
Nucleosome structure and chromatin packaging are already known to sequester RSSs from the RAGs [31] . Our findings suggest a further hierarchy of RSS protection provided by the chromatin (most likely remodeled) and the N-terminal 218 amino acids of RAG1. The ring-finger domain's E3 activity prepares full-length RAG1 for the initiation of cleavage via the ubiquitylation of histone H3. Our results suggest that ubiquitylation of histone H3 spatially releases RAG1, however, we could not rule out the possibility that this transition into cleavage may also involve a conformational change in RAG1 [16] . The spatial release and an active conformation could be triggered simultaneously, and they are not necessarily mutually exclusive.
A previous study reported that after 48 h of co-transfection with episomal substrates, RAG1 containing the ring-domain mutation generates more signal ends than wild-type RAG1 [18] . When we shifted the time point to 24 h after the co-transfection, we found a comparable level of signal ends and decreased joints generated by RAG1 C325Y compared to wild-type RAG1. Collectively, these data suggest that RAG1
C325Y might be somewhat defective in the joining phase. A previous study found that although the V(D)J recombination mediated by some RAG1 N-terminal mutants is impaired, such impairment can be partially rescued by higher expression of the mutants [29] . That RAG1 and RAG1 C325Y exhibited comparable cleavage ability in HEK-293T cells ( Figure 3D ) might as well be due to their high expression levels. We could not rule out the possibility that RAG1 C325Y might be partially defective in the cleavage of episomal substrates.
Our results provide a model that chromatin functions in a "recruit", "restrain" and "release" pattern prior to the initiation of V(D)J recombination. This new perspective regarding the relationship between non-core RAG1 and nucleosomes enriches our understanding of V(D)J recombination. Although the RAG1 KI/KI mice showed a normal appearance at birth, the majority of them after the age of 8 weeks gradually began to exhibit hair loss, erythroderma and colitis-autoimmune phenotypes mimicking OS. Preliminary analysis showed that peripheral T cells were hyperactive in these mice (data not shown). Further study of cellular mechanisms such as T cell tolerance and expansion in these mice will enhance our understanding of OS pathophysiology.
Materials and Methods
Mice
RAG1
KI/KI mice were generated by gene targeting. In brief, a targeting vector containing a C325Y mutation in a Kpn1/BamH1 fragment (covering the Rag1 coding region), a diphtheria toxin A negative selection cassette and a Neo-positive cassette was intro- duced into embryonic stem (ES) cells by electroporation. Targeted ES clones were first identified by PCR with a forward primer located upstream of the 5′ homologous arm and a reverse primer downstream of the Neo cassette. PCR products were further sequenced to verify the existence of mutation site. Positive clones were next analyzed by Southern blot using a probe located downstream of the 3′ homologous arm (a 1 500-bp fragment). The selected ES clone was then microinjected into C57BL/6 blastocysts to produce chimeric mice. Male chimeras were bred to C57BL/6 female mice to generate heterozygous progeny mice. By crossing with CmvCre mice, the floxed Neo cassette was removed.
OT-1 TCR transgenic mice, RAG1 −/− mice and RAG2 −/− mice were obtained from the Jackson Laboratory. All mice were maintained in specific pathogen-free facilities at the Shanghai Laboratory Animal Center. All mice were genotyped using PCR before experimentation. All animal experiments were approved by The Institutional Animal Use Committee of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences.
Antibodies and reagents
For the flow cytometry analysis, anti-CD4 (GK1.5), anti-CD8a (53-6.7), anti-B220 (RA3-6B2), anti-CD11b (M1/70), anti-CD3e (145-2C11), anti-CD43 (S7), anti-CD44 (IM7), anti-TCRβ (H57), anti-Ter119 (TER-119), anti-Gr-1(RB6-8C5), anti-IgM (R6-60.2) and anti-CD25 (PC61) were purchased from BD Biosciences.
In IP and co-IP assays, anti-FLAG (M2) mAb (F3165), and the affinity gel (A2220) were purchased from Sigma-Aldrich, anti-HA (sc-805) was purchased from Santa Cruz Biotechnology, the glutathione sepharose 4B (27-4574-01) was purchased from GE and the anti-histone H3 (ab1791) was purchased from Abcam.
For western blots, the anti-RAG1 (sc-363, sc-5599), anti-GST (sc-138) and anti-ubiquitin (sc-166553) antibodies were purchased from Santa Cruz Biotechnology. An additional anti-ubiquitin (ab134953) antibody was purchased from Abcam.
The 2× Taq Master Mix used in PCR was purchased from Vazyme, and the SYBER Green Master Mix used in the real-time PCR was purchased from Toyobo.
Iodoacetamide, N-ethylmaleimide and MG-132 were purchased from Sigma-Aldrich.
Detection of endogenous rearrangement by PCR
A single-cell suspension was prepared, and the surface was stained as previously described [32, 33] . DN3 cells (CD4 − CD8 − CD44 − CD25 + ) and Pro-B cells (B220 + IgM − CD43 high ) were sorted by a FACSAria II (BD Biosciences). Genomic DNA was prepared as previously described [32] . The Tcrb recombination products were detected as previously described [32] , as were the Igh recombination products [15] . LM-PCR was carried out as previously described [15] .
To quantify the D β 1-J β 1.6 coding joints and D β 1-J β 1.1 signal joints, DN3 genomic DNA was digested with EcoRI and EcoRV and then recovered. Cd14 was used as an internal control. The junction levels relative to that of the first control sample (given a value of 100) were normalized by the mean value of the control group from three independent experiments. The following primer pairs were used: D β 1-J β 1.6-CJ: 5′-AGAAGGGCGGATACAAGA-3 and 5′-AGATGGGAAGGGACGACT-3′; D β 1-J β 1.1-SJ: 5′-GAG-GGAATCTACCATGTTTGAC-3′ and 5′-TTATGGACGTTGG-CAGAAGAGGAT-3′; and Cd14: 5′-CCTAGTCGGATTCTATTC-GGAGCC-3′ and 5′-AACTTGGAGGGTCGGGAACTTG-3′.
Recombination assays in HEK-293T cells
Recombination substrate plasmids (pJH289 or pJH290, 0.7 µg), N-FLAG-RAG1-pcDNA3.1 or N-FLAG-RAG1 C325Y -pcDNA3.1 (1.5 µg) and pEBG-RAG2 (1.5 µg) were co-transfected into 293T cells [34] . After 24 h, the transfected DNA was recovered by alkaline lysis. To analyze the recombination products, the recovered DNA was amplified by 25 cycles of PCR. All of the recombination products amplified by PCR were confirmed by sequencing. The following primer pairs were used: for pJH289-SJ and pJH290-CJ, 5′-CCCCAGGCTTTACACTTT-3′ and 5′-CCGTCTTTCATTGC-CATAC-3′; for pJH289 and pJH290 input, 5′-TCTTTATAGTCCT-GTCGGGTTT-3′ and 5′-GCGGTAATACGGTTATCCAC-3.
The recombination substrate plasmids (pSJGFP or pCJGFP, 0.7 µg), N-FLAG-RAG1-pcDNA3.1 or N-FLAG-RAG1 C325Y -pcD-NA3.1 (1.5 µg) and pEBG-RAG2 (1.5 µg) were co-transfected into 293T cells [35] . After 24 h, the signal joints and coding joints were assessed by determining the ratios of cells expressing GFP.
To analyze the signal end, the recovered DNA was ligated with a BW linker (BW1: 5′-GCGGTGACCCGGGAGATCTGAAT-TC-3′, BW2: 5′-GAATTCAGATC-3′).
The primer pairs used were as follows: for the 12RSS signal end, 5′-CCGGGAGATCTGAATTCCAC-3′ and 5′-CCCCAG-GCTTTACACTTT-3′; for the 23 RSS signal end, 5′-CCGG-GAGATCTGAATTCCAC-3′ and 5′-CCGTCTTTCATTGCCAT-AC-3′.
Cell lines and transient transfection
HEK-293T cells and Plat-E cells were transfected using calcium phosphate precipitation and maintained in DMEM. Freshly isolated thymocytes were electroporated and maintained in DMEM (20% FBS and 100 U/ml IL-7).
Anti-histone H3 immunoprecipitation
Iodoacetamide (final concentration 10 mM), N-ethylmaleimide (final concentration 10 mM), MG123 (final concentration 20 mM) and protease inhibitor cocktail were added into the immunoprecipitation buffer (20 mM Tris-HCl, pH 7.4, 200 mM NaCl, 1 mM EDTA, 0.1% (m/v) SDS and 5% (v/v) glycerol) before use. For in vivo IP, 1 × 10 6 fresh DN3 cells were sorted from the indicated mice and lysed on ice. After sonication and precipitation, the supernatant was gently agitated at 4 °C with anti-histone H3 (prelinked with protein A/G) for 5 h. For the HEK-293T cell IP, the supernatant of 1 × 10 7 transfected HEK-293T cells was gently agitated with anti-FLAG M2 gel at 4 °C for 5 h. The precipitates were washed three times with immunoprecipitation buffer and eluted in SDS loading buffer.
Co-immunoprecipitation and GST precipitation assay
For the co-immunoprecipitation and GST precipitation assays, 1 × 10 7 HEK-293T cells were lysed and sonicated in lysis buffer (20 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% (v/v) Triton X-100, and 5% (v/v) glycerol) with the protease inhibitors, iodoacetamide (final concentration 10 mM), N-ethylmaleimide (final concentration 10 mM) and MG123 (final concentration 20 mM) added to preserve the ubiquitylated proteins in the lysis buffer. After precipitation, the supernatant was gently agitated with npg www.cell-research.com | Cell Research anti-HA antibody (pre-linked with proteinA/G), anti-FLAG M2 gel or GST-sepharose at 4 °C for 12 h. The precipitates were washed three times with lysis buffer and eluted in SDS loading buffer.
Retroviral bone marrow transfer
Retrovirus-mediated gene transfer (based on pMCs-IRES-GFP vector) was performed as previously described [33] . Bone marrow cells were isolated from the indicated mice 5 day after the injection of 5-fluorouracil and maintained in pre-stimulation medium supplemented with 50 ng/ml rmSCF, 6 ng/ml rmIL-3 and 10 ng/ml rmIL-6 (PeproTech) for 18-24 h. After the retrovirus infection [33, 36] , 1 × 10 6 bone marrow cells were injected into each 750 cGy-irradiated recipient. After 3-4 week, thymocytes and bone marrow cells were isolated from the recipients and analyzed to assess T and B lymphocyte differentiation.
Statistical analysis
All data are expressed as the mean ± SEM. The results were analyzed by Student's t-test. P values < 0.05 were considered statistically significant.
